| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |